APH — Alliance Pharma Cashflow Statement
0.000.00%
- £210.22m
- £305.19m
- £180.68m
- 46
- 72
- 51
- 58
Annual cashflow statement for Alliance Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 25 | 8.03 | 7.32 | 0.936 | -33.1 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 14.5 | 22 | 16.5 | 37.2 | 73.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5.46 | 2.61 | -1.42 | -18.7 | -19.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 35.8 | 41.6 | 38.7 | 21 | 31.4 |
Capital Expenditures | -4.16 | -4.61 | -5.53 | -0.607 | -0.696 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.873 | -81.3 | 0.933 | -16.4 | -0.222 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3.28 | -85.9 | -4.6 | -17 | -0.918 |
Financing Cash Flow Items | -3.91 | -3.23 | -2.96 | -4.8 | -10.8 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -25.2 | 55.7 | -34.3 | -0.876 | -39.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 6.94 | 11.1 | 0.163 | 2.65 | -9.28 |